News Social Network for MS Patients Launched by Curatio and BioScript Solutions Social Network for MS Patients Launched by Curatio and BioScript Solutions by Patricia Silva, PhD | May 10, 2018 Share this article: Share article via email Copy article link Curatio and BioScript Solutions recently launched a mobile patient engagement platform designed to provide multiple sclerosis (MS) patients with a way to connect, share experiences, and gain new knowledge. The private, free social network app was introduced at the recent HLTH conference, which took place May 6-9 in Las Vegas. Created to help reduce the isolation, stigma, and loneliness that often accompanies disease, the app provides peer support, reliable information, and personalized programs for MS patients. It combines matchmaking technology, curated content, and easy-to-use disease tracking tools to further empower and support patients. “As a society, we are starting to understand the detrimental and costly impact that isolation has on health outcomes and well-being. No patient should be alone when managing a health condition. The symptoms that people living with MS experience are particularly isolating and impact everything from quality of life to adherence to eventual outcomes,” Lynda Brown-Ganzert, founder and CEO of Curatio, said in a press release. “Curatio helps partners, like BioScript Solutions, deliver private, social, patient support programs that combine personalized support with daily disease management for an all-in-one solution that drives better health outcomes and most importantly, better lives,” she said. Through the app, patients can connect with “buddies” with Curatio’s matchmaking technology, track and manage their symptoms on a daily basis, and participate in personalized programs, self-assessments, and research surveys that provide new insight and knowledge. It is available for download on iOS and Android devices. The platform is also available for licensing to hospitals and healthcare providers, pharmaceutical companies, payers, and government and non-governmental organizations. “From a specialty pharmacy perspective, we’ve been searching for a technology solution to complement the high-touch, personalized services we provide our patients. It’s been challenging to find a technology platform that provides patients both a private and personalized experience, yet has the ability to easily scale across our entire patient population. Curatio provides exactly that. We are excited to launch this innovative solution to the patients and partners we serve,” said Jeff Wandzura, vice president of innovation for BioScript Solutions. MS was estimated to affect 947,000 people in the U.S. in a recent study funded by the National Multiple Sclerosis Society — more than twice the 400,000 figure researchers had long used for reference. It is considered to be the most widespread disabling neurological condition among young adults in the world. The isolation and loneliness that MS patients often experience can further affect their health and well-being. The Curatio app is intended to alleviate this isolation and help MS patients choose the type of support they need. Print This Page About the Author Patricia Silva, PhD Patrícia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. Patrícia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles. Tags app, mental health, stigma
April 26, 2024 News by Margarida Maia, PhD Employment, income drop steadily over 2 decades after onset of MS
April 26, 2024 News by Marisa Wexler, MS Machine learning model predicts CIS to MS conversion risk: Study
April 25, 2024 Columns by Benjamin Hofmeister Finding safety while living with the constant threat of MS progression